Annual Current Liabilities
$23.09 M
+$13.14 M+131.95%
December 31, 2022
Summary
- As of February 8, 2025, ELOX annual total current liabilities is $23.09 million, with the most recent change of +$13.14 million (+131.95%) on December 31, 2022.
- During the last 3 years, ELOX annual current liabilities has risen by +$11.28 million (+95.57%).
- ELOX annual current liabilities is now at all-time high.
Performance
ELOX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$23.47 M
+$2.21 M+10.42%
September 30, 2023
Summary
- As of February 8, 2025, ELOX quarterly total current liabilities is $23.47 million, with the most recent change of +$2.21 million (+10.42%) on September 30, 2023.
- Over the past year, ELOX quarterly current liabilities has increased by +$1.79 million (+8.24%).
- ELOX quarterly current liabilities is now at all-time high.
Performance
ELOX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ELOX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +131.9% | +8.2% |
| 3 y3 years | +95.6% | +135.0% |
| 5 y5 years | +574.6% | +200.6% |
ELOX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +131.9% | at high | +135.7% |
| 5 y | 5-year | at high | +134.7% | at high | +146.8% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Eloxx Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $23.47 M(+10.4%) |
| Jun 2023 | - | $21.25 M(+9.2%) |
| Mar 2023 | - | $19.46 M(-15.7%) |
| Dec 2022 | $23.09 M(+132.0%) | $23.09 M(+6.5%) |
| Sep 2022 | - | $21.68 M(+11.2%) |
| Jun 2022 | - | $19.50 M(+1.7%) |
| Mar 2022 | - | $19.17 M(+92.6%) |
| Dec 2021 | $9.96 M(+1.2%) | $9.96 M(+4.7%) |
| Sep 2021 | - | $9.51 M(-37.5%) |
| Jun 2021 | - | $15.21 M(+19.8%) |
| Mar 2021 | - | $12.69 M(+29.0%) |
| Dec 2020 | $9.84 M(-16.7%) | $9.84 M(-1.5%) |
| Sep 2020 | - | $9.98 M(-7.3%) |
| Jun 2020 | - | $10.77 M(-2.8%) |
| Mar 2020 | - | $11.08 M(-6.1%) |
| Dec 2019 | $11.81 M(+51.2%) | $11.81 M(+5.2%) |
| Sep 2019 | - | $11.23 M(+2.1%) |
| Jun 2019 | - | $10.99 M(+30.5%) |
| Mar 2019 | - | $8.42 M(+7.9%) |
| Dec 2018 | $7.81 M(+128.1%) | $7.81 M(+53.7%) |
| Sep 2018 | - | $5.08 M(+16.6%) |
| Jun 2018 | - | $4.36 M(-22.9%) |
| Mar 2018 | - | $5.65 M(+425.0%) |
| Dec 2017 | $3.42 M(+23.4%) | - |
| Sep 2017 | - | $1.08 M(-61.2%) |
| Jun 2017 | - | $2.77 M(+162.3%) |
| Jun 2017 | $2.77 M(+651.8%) | - |
| Mar 2017 | - | $1.06 M(+38.4%) |
| Dec 2016 | - | $764.20 K(+63.5%) |
| Sep 2016 | - | $467.30 K(+26.6%) |
| Jun 2016 | $369.00 K(-52.6%) | $369.00 K(-2.2%) |
| Mar 2016 | - | $377.30 K(-33.7%) |
| Dec 2015 | - | $569.20 K(-15.7%) |
| Sep 2015 | - | $675.50 K(-13.2%) |
| Jun 2015 | $778.50 K(-57.3%) | $778.50 K(-53.0%) |
| Mar 2015 | - | $1.66 M(-35.1%) |
| Dec 2014 | - | $2.55 M(+51.1%) |
| Sep 2014 | - | $1.69 M(-7.6%) |
| Jun 2014 | $1.83 M(-43.2%) | $1.83 M(+73.0%) |
| Mar 2014 | - | $1.06 M(-67.8%) |
| Dec 2013 | - | $3.28 M(-8.8%) |
| Sep 2013 | - | $3.60 M(+12.0%) |
| Jun 2013 | $3.21 M(+1.5%) | $3.21 M(-0.2%) |
| Mar 2013 | - | $3.22 M(-14.2%) |
| Dec 2012 | - | $3.75 M(+9.2%) |
| Sep 2012 | - | $3.44 M(+8.6%) |
| Jun 2012 | $3.16 M(-3.2%) | $3.16 M(-10.5%) |
| Mar 2012 | - | $3.53 M(+2.5%) |
| Dec 2011 | - | $3.45 M(-9.3%) |
| Sep 2011 | - | $3.80 M(+16.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2011 | $3.27 M(-1.8%) | $3.27 M(+1.3%) |
| Mar 2011 | - | $3.23 M(+1.0%) |
| Dec 2010 | - | $3.20 M(-7.1%) |
| Sep 2010 | - | $3.44 M(+3.3%) |
| Jun 2010 | $3.33 M(+149.8%) | $3.33 M(-22.6%) |
| Mar 2010 | - | $4.30 M(+186.3%) |
| Dec 2009 | - | $1.50 M(+52.3%) |
| Sep 2009 | - | $987.30 K(-25.9%) |
| Jun 2009 | $1.33 M(+94.7%) | $1.33 M(+36.9%) |
| Mar 2009 | - | $973.10 K(+10.3%) |
| Dec 2008 | - | $882.00 K(-0.5%) |
| Sep 2008 | - | $886.80 K(+29.6%) |
| Jun 2008 | $684.40 K(+36.0%) | $684.40 K(+0.9%) |
| Mar 2008 | - | $678.10 K(-26.7%) |
| Dec 2007 | - | $924.80 K(+12.6%) |
| Sep 2007 | - | $821.50 K(+63.2%) |
| Jun 2007 | $503.30 K(+12.0%) | $503.30 K(+44.8%) |
| Mar 2007 | - | $347.50 K(-13.3%) |
| Dec 2006 | - | $401.00 K(-41.4%) |
| Sep 2006 | - | $683.80 K(+52.2%) |
| Jun 2006 | $449.20 K(+4.2%) | $449.20 K(-43.5%) |
| Mar 2006 | - | $794.90 K(+57.3%) |
| Dec 2005 | - | $505.20 K(+16.3%) |
| Sep 2005 | - | $434.30 K(+0.8%) |
| Jun 2005 | $430.90 K(+10.5%) | $430.90 K(+21.9%) |
| Mar 2005 | - | $353.60 K(-16.5%) |
| Dec 2004 | - | $423.60 K(+6.6%) |
| Sep 2004 | - | $397.30 K(+1.9%) |
| Jun 2004 | $390.00 K(+22.1%) | $390.00 K(-27.1%) |
| Mar 2004 | - | $534.90 K(+24.5%) |
| Dec 2003 | - | $429.80 K(+6.3%) |
| Sep 2003 | - | $404.40 K(+26.7%) |
| Jun 2003 | $319.30 K(-15.2%) | $319.30 K(-25.3%) |
| Mar 2003 | - | $427.70 K(+23.4%) |
| Dec 2002 | - | $346.70 K(-29.9%) |
| Sep 2002 | - | $494.80 K(+31.4%) |
| Jun 2002 | $376.50 K(-13.4%) | $376.50 K(+50.2%) |
| Mar 2002 | - | $250.70 K(-42.9%) |
| Dec 2001 | - | $438.80 K(-48.3%) |
| Sep 2001 | - | $848.40 K(+95.2%) |
| Jun 2001 | $434.70 K(+92.9%) | $434.70 K(+33.8%) |
| Mar 2001 | - | $324.80 K(+48.2%) |
| Dec 2000 | - | $219.20 K(+2.7%) |
| Sep 2000 | - | $213.40 K(-5.3%) |
| Jun 2000 | $225.30 K(+30.5%) | $225.30 K(-27.6%) |
| Mar 2000 | - | $311.40 K(+55.7%) |
| Dec 1999 | - | $200.00 K |
| Jun 1999 | $172.60 K(+5467.7%) | - |
| Jun 1998 | $3100.00(-11.4%) | - |
| Jun 1997 | $3500.00 | - |
FAQ
- What is Eloxx Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals annual current liabilities year-on-year change?
- What is Eloxx Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals quarterly current liabilities year-on-year change?
What is Eloxx Pharmaceuticals annual total current liabilities?
The current annual current liabilities of ELOX is $23.09 M
What is the all time high annual current liabilities for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high annual total current liabilities is $23.09 M
What is Eloxx Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, ELOX annual total current liabilities has changed by +$13.14 M (+131.95%)
What is Eloxx Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of ELOX is $23.47 M
What is the all time high quarterly current liabilities for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high quarterly total current liabilities is $23.47 M
What is Eloxx Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, ELOX quarterly total current liabilities has changed by +$1.79 M (+8.24%)